Bruce W. Stillman, PhD
President and Chief Executive Officer
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York
Dr. Bruce Stillman is a native of Australia. He graduated with a Bachelor of Science degree with first class honors at The University of Sydney and a Ph.D. at the John Curtin School of Medical Research at the Australian National University. He then moved to Cold Spring Harbor Laboratory as a Postdoctoral Fellow in 1979 and has been at the Laboratory ever since, being promoted to the scientific staff in 1981. Dr. Stillman has been Director of the Cancer Center at Cold Spring Harbor Laboratory since 1992, a position he still holds. In 1994, he succeeded Nobel laureate James D. Watson as Director of Cold Spring Harbor Laboratory and was appointed President in 2003.
Dr. Stillman's research focuses on the mechanism and regulation of duplication of DNA and chromatin in cells, a process that ensures accurate inheritance of genetic information from one cell generation to the next. He was awarded the Order of Australian (AO) in 1999 for his medical research. He was elected to The Royal Society (UK), the National Academy of Sciences, the Australian Academy of Sciences and the American Academy of Arts and Sciences. Dr. Stillman was awarded the 2004 Alfred P. Sloan Prize from the General Motors Cancer Research Foundation and the 2010 Louisa Gross Horwitz Prize from Columbia University, both with Dr. Thomas Kelly of Memorial Sloan Kettering Cancer Center. He is a recipient of the American Cancer Society Basic Science Award from the Society of Surgical Oncology and the Curtin Medal from the Australian National University. This year he was awarded the Herbert Tabor Research Award from The American Society for Biochemistry and Molecular Biology (ASBMS).
He is the past co-chair of the Board of Scientific Counselors of the National Cancer Institute and was vice-chair of the National Cancer Policy Board as well as a former member of the Board of Life Sciences of the National Research Council. Currently, Dr. Stillman is a member of the Medical Advisory Board of the Howard Hughes Medical Institute, the advisory boards for Koch Institute for Integrative Cancer Research at MIT and the Lewis Sigler Institute at Princeton University and the Board of Scientific Advisors of the National Cancer Institute. He also consults for a number of corporations and foundations.